The US Food and Drug Administration (FDA) is warning the Americans to be cautious before getting the ‘young blood’ transfused as it has become a hot topic in experimental treatments to block aging and Alzheimer’s disease.
Several of the of recent studies on both animals and humans have suggested that compounds in youngster’s blood may help treat conditions of old age, including Parkinson’s and aging itself.
A few clinics offering the controversial transfusions have cropped up already in the US and abroad.
But the FDA warned today that there are no proven – much less approved – benefits of younger donor blood and that the procedure’s safety has not been established.
The FDA also warned that it’s not just that the benefits are not proven, but the risks of young blood transfusions may be quite significant.